| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | TETRAPHASE PHARMACEUTICALS INC COM | 698,000 | 2,813,000 | 0.19% | ||
| 102 | ADAPTIMMUNE THERAPEUTICS PLC | 675,000 | 2,734,000 | 0.18% | ||
| 103 | HILL ROM HLDGS INC | 47,500 | 2,667,000 | 0.18% | ||
| 104 | EXELIXIS INC | 175,000 | 2,609,000 | 0.17% | ||
| 105 | MADRIGAL PHARMACEUTICALS INC | 174,891 | 2,606,000 | 0.17% | ||
| 106 | DBV TECHNOLOGIES S A | 73,000 | 2,564,000 | 0.17% | ||
| 107 | SCYNEXIS INC | 760,000 | 2,424,000 | 0.16% | ||
| 108 | RIGEL PHARMACEUTICAL INC | 1,000,000 | 2,380,000 | 0.16% | ||
| 109 | Egalet Corp | 300,000 | 2,295,000 | 0.15% | ||
| 110 | AEGLEA BIOTHERAPEUTICS INC | 524,089 | 2,280,000 | 0.15% | ||
| 111 | ZIMMER BIOMET HLDGS INC | 21,100 | 2,178,000 | 0.15% | ||
| 112 | SERES THERAPEUTICS INC | 220,000 | 2,178,000 | 0.15% | ||
| 113 | HEALTHEQUITY INC | 50,000 | 2,026,000 | 0.14% | ||
| 114 | GENOCEA BIOSCIENCES INC | 480,000 | 1,978,000 | 0.13% | ||
| 115 | BLUEBIRD BIO INC COM | 28,500 | 1,758,000 | 0.12% | ||
| 116 | THERAVANCE BIOPHARMA INC | 1,500,000 | 1,713,000 | 0.11% | PRN | |
| 117 | NOVOCURE LTD | 214,316 | 1,682,000 | 0.11% | ||
| 118 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 96,500 | 1,394,000 | 0.09% | ||
| 119 | TANDEM DIABETES CARE INC COM | 595,000 | 1,279,000 | 0.09% | ||
| 120 | DIMENSION THERAPEUTICS INC | 271,370 | 1,180,000 | 0.08% | ||
| 121 | MYOVANT SCIENCES LTD | 89,600 | 1,115,000 | 0.07% | ||
| 122 | Nivalis Therapeutics Inc | 489,000 | 1,095,000 | 0.07% | ||
| 123 | WRIGHT MED GROUP INC SR CONV NT 2 20 | 1,000,000 | 1,047,000 | 0.07% | PRN | |
| 124 | VALEANT PHARMACEUTICALS INTL | 71,400 | 1,037,000 | 0.07% | ||
| 125 | NOVAVAX INC COM | 820,000 | 1,033,000 | 0.07% | ||
| 126 | Life Technologies Corp | 475,000 | 1,021,000 | 0.07% | ||
| 127 | CHIASMA INC | 492,500 | 960,000 | 0.06% | ||
| 128 | PERRIGO CO PLC | 9,300 | 774,000 | 0.05% | ||
| 129 | DYNAVAX TECHNOLOGIES CORP | 165,000 | 652,000 | 0.04% | ||
| 130 | CERULEAN PHARMA INC | 625,000 | 443,000 | 0.03% | ||
| 131 | INFINITY PHARMACEUTICALS INC | 270,000 | 365,000 | 0.02% | ||
| 132 | OREXIGEN THERAPEUTICS INC | 165,300 | 288,000 | 0.02% | ||
| 133 | ANTHERA PHARMACEUTICALS I | 380,000 | 247,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-000700, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
